Yiviva is a biotechnology company developing therapeutics to treat cancer, chronic, and inflammatory diseases. It offers STAR (Signal Transduction, Action and Response) discovery platform screening high potential herbs from traditional medicine, gaining insights into how different herbs act on key pathways and affect biological responses, etc. The company also provides a candidate cancer drug YIV-906.